Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
F 11.31 0.18% 0.02
AUPH closed up 0.53 percent on Wednesday, May 12, 2021, on 1.96 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AUPH trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.18%
Stochastic Buy Signal Bullish 0.18%
Calm After Storm Range Contraction 0.18%
Lower Bollinger Band Walk Weakness 0.18%
Earnings Movers Other 0.18%
Oversold Stochastic Weakness 0.18%
Bullish Engulfing Bullish 0.71%
Lower Bollinger Band Walk Weakness 0.71%
New 52 Week Low Weakness 0.71%
Multiple of Ten Bullish Other 0.71%
Older End-of-Day Signals for AUPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 12 minutes ago
2x Volume Pace about 1 hour ago
1.5x Volume Pace about 1 hour ago
Rose Above Previous Day's High about 2 hours ago
10 DMA Resistance about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Life Sciences Clinical Development Drugs Autoimmune Diseases Autoimmune Disease Peptides Lupus Nephrology Immunosuppressants Lupus Nephritis Nephritis

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.5
52 Week Low 9.721
Average Volume 3,678,869
200-Day Moving Average 14.16
50-Day Moving Average 12.70
20-Day Moving Average 12.08
10-Day Moving Average 11.74
Average True Range 0.83
ADX 15.05
+DI 27.66
-DI 25.72
Chandelier Exit (Long, 3 ATRs ) 11.34
Chandelier Exit (Short, 3 ATRs ) 12.20
Upper Bollinger Band 13.72
Lower Bollinger Band 10.44
Percent B (%b) 0.26
BandWidth 27.14
MACD Line -0.50
MACD Signal Line -0.37
MACD Histogram -0.1307
Fundamentals Value
Market Cap 1.43 Billion
Num Shares 126 Million
EPS -0.70
Price-to-Earnings (P/E) Ratio -16.20
Price-to-Sales 13945.98
Price-to-Book 4.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.40
Resistance 3 (R3) 12.43 12.08 12.22
Resistance 2 (R2) 12.08 11.80 12.07 12.15
Resistance 1 (R1) 11.69 11.63 11.89 11.66 12.09
Pivot Point 11.34 11.34 11.44 11.33 11.34
Support 1 (S1) 10.95 11.06 11.15 10.92 10.49
Support 2 (S2) 10.60 10.89 10.59 10.43
Support 3 (S3) 10.21 10.60 10.37
Support 4 (S4) 10.18